Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

RNA-seq03:21

RNA-seq

RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases. 
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while microarray-based...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Membrane phospholipids in the regulation of tissue factor procoagulant function.

Current opinion in hematology·2026
Same author

M1C mediates LINE-1 transcription in PARP inhibitor-treated prostate cancer cells.

Cancer letters·2026
Same author

MUCIN 1 confers inflammatory memory of tyrosine kinase inhibitor resistance in non-small cell lung cancer.

Signal transduction and targeted therapy·2025
Same author

Targeting KRAS Inhibitor-Resistant Pancreatic Cancer with an MUC1-C Antibody-Drug Conjugate.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

Activation of APOBEC3 cytidine deaminases and endogenous retroviruses is integrated by MUC1-C in NSCLC cells.

Cell death discovery·2025
Same author

MUC1-C auto-regulatory complex with EBNA1 is responsible for latent Epstein-Barr virus-associated gastric cancer progression.

Oncogene·2025
Same journal

Topological skeleton analysis for network-based shape representation in biology and beyond.

iScience·2026
Same journal

Condition-specific neural signatures of reactivation during post-retrieval rest: An EEG study.

iScience·2026
Same journal

Multi-chaotic signal identification employing a causal cross-correlation neural network.

iScience·2026
Same journal

Repeated insertions at positions 261-280 in KPC-2 highlight a ceftazidime-avibactam resistance hotspot.

iScience·2026
Same journal

ROS inhibits microtubule dynamics and cell growth heterogeneity during Arabidopsis sepal morphogenesis.

iScience·2026
Same journal

Type 1 diabetes alters early macrophage-<i>Mycobacterium tuberculosis</i> transcriptional coordination during infection.

iScience·2026
See all related articles

Related Experiment Video

Updated: Jun 28, 2026

A Single Cell Dissociation Approach for Molecular Analysis of Urinary Bladder in the Mouse Following Spinal Cord Injury
09:50

A Single Cell Dissociation Approach for Molecular Analysis of Urinary Bladder in the Mouse Following Spinal Cord Injury

Published on: June 17, 2020

5.5K

Single-cell RNA sequencing and spatial transcriptomics of bladder Ewing sarcoma.

Weipu Mao1, Kangjie Xu2, Keyi Wang3

  • 1Department of Urology, Affiliated Zhongda Hospital of Southeast University, Nanjing 210009, China.

Iscience
|October 10, 2024
PubMed
Summary
This summary is machine-generated.

Researchers uncovered novel cell types and signaling pathways in bladder Ewing sarcoma/primitive neuroectodermal tumor (ES/PNET). Mast cells activate epithelial cells via TNFSF12-TNFRSF12A signaling, suggesting Enavatuzumab as a potential therapy.

Keywords:
cancermolecular biologytranscriptomics

More Related Videos

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
09:58

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Published on: June 27, 2020

2.7K
Author Spotlight: A Pipeline to Analyze Lineage-Specific Mutant Embryos at Single-Cell Resolution
09:14

Author Spotlight: A Pipeline to Analyze Lineage-Specific Mutant Embryos at Single-Cell Resolution

Published on: June 14, 2024

777

Related Experiment Videos

Last Updated: Jun 28, 2026

A Single Cell Dissociation Approach for Molecular Analysis of Urinary Bladder in the Mouse Following Spinal Cord Injury
09:50

A Single Cell Dissociation Approach for Molecular Analysis of Urinary Bladder in the Mouse Following Spinal Cord Injury

Published on: June 17, 2020

5.5K
Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
09:58

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Published on: June 27, 2020

2.7K
Author Spotlight: A Pipeline to Analyze Lineage-Specific Mutant Embryos at Single-Cell Resolution
09:14

Author Spotlight: A Pipeline to Analyze Lineage-Specific Mutant Embryos at Single-Cell Resolution

Published on: June 14, 2024

777

Area of Science:

  • Oncology
  • Molecular Biology
  • Genomics

Background:

  • Bladder Ewing sarcoma/primitive neuroectodermal tumor (ES/PNET) is a rare, aggressive malignancy with poorly understood pathogenesis.
  • Existing treatments for bladder ES/PNET are limited, highlighting the need for novel therapeutic strategies.

Purpose of the Study:

  • To elucidate the underlying molecular mechanisms and cellular interactions driving bladder ES/PNET development.
  • To identify potential therapeutic targets for bladder ES/PNET.

Main Methods:

  • Single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics (ST) were utilized to analyze tumor microenvironments.
  • Functional assays were performed to investigate cell-cell interactions and drug efficacy.

Main Results:

  • Identified unique epithelial (bladder ES-Epi) and mast cell (bladder ES-Mast) populations within bladder ES/PNET.
  • Discovered TNFSF12-TNFRSF12A ligand-receptor signaling mediating mast cell activation of epithelial cells.
  • Demonstrated Enavatuzumab's efficacy in inhibiting Ewing sarcoma cell line migration.

Conclusions:

  • Bladder ES/PNET pathogenesis involves specialized cell types and specific signaling pathways.
  • The TNFSF12-TNFRSF12A axis presents a promising therapeutic target for bladder ES/PNET.
  • Enavatuzumab shows potential as a novel treatment for this rare cancer.